Title:
抗転移性２Ｈ‐セレノフェノ［３，２‐ｈ］クロメン、それらの合成、および同薬剤の使用方法
Document Type and Number:
Japanese Patent JP6779318
Kind Code:
B2
Abstract:
The present invention relates to a novel cancer metastasis preventing and curing selenopheno[h]chromene derivatives, as well as methods of their manufacturing and use in different pharmaceutical compositions for the treatment and/or prevention of primary cancer and its metastasis by administration of such substances.
Inventors:
Arsenans, Pavels
Vasilieva, Irena
Domrakeva, Ilona
Shestakova, Irina
Calvinche, Ibals
Vasilieva, Irena
Domrakeva, Ilona
Shestakova, Irina
Calvinche, Ibals
Application Number:
JP2018566352A
Publication Date:
November 04, 2020
Filing Date:
July 21, 2016
Export Citation:
Assignee:
LATVIAN INSTITUTE OF ORGANIC SYNTHESIS
International Classes:
C07D517/04; A61K31/453; A61K31/496; A61K31/5377; A61K31/585; A61K45/00; A61P35/00; A61P35/04; C07J51/00
Foreign References:
| WO2009152210A1 | ||||
| US20090312406 |
Other References:
ARSENYAN, P. et al,Synthesis and molecular structure of the methyl ester of 3-bromo-2-(2-hydroxy-2-propyl)-7-oxo-7H-selenolo[2,3-f]chromene-8-carboxylic acid,Chemistry of Heterocyclic Compounds,2011年,Vol.47, No.2,pp.237-241
ARSENYAN, P. et al.,Selenopheno[3,2-c]- and [2,3-c]coumarins: Synthesis, cytotoxicity, angiogenesis inhibition, and antioxidant properties,Comptes Rendus Chimie,2015年,Vol.18,pp.399-409
ARSENYAN, P. et al.,Selenopheno[3,2-c]- and [2,3-c]coumarins: Synthesis, cytotoxicity, angiogenesis inhibition, and antioxidant properties,Comptes Rendus Chimie,2015年,Vol.18,pp.399-409
Attorney, Agent or Firm:
Tomimasa Konishi
Tomoko Nakamura
Tomoko Nakamura